特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

眼科向け画像装置:医療機器のパイプライン評価

Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 347933
出版日 ページ情報 英文 127 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
眼科向け画像装置:医療機器のパイプライン評価 Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月16日 ページ情報: 英文 127 Pages
概要

当レポートでは、世界の眼科向け画像装置市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 眼科向け画像装置市場の概要

第3章 眼科向け画像装置市場:治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 眼科向け画像装置の企業:治験段階別のパイプライン製品
  • 眼科向け画像装置:治験段階別のパイプライン製品

第5章 眼科向け画像装置市場:企業・製品の概要

  • Aeon Imaging, LLC
    • パイプライン製品および進行中の治験の概要
  • Aeon Scientific AG
  • ArcScan, Inc.
  • Brien Holden Vision Institute
  • CW Optics, Inc.
  • Dalhousie University
  • Exploit Technologies Pte Ltd
  • Eye Marker Systems, Inc.
  • Eyenuk Inc.
  • EyeTechCare SA
  • Gemss Co.,Ltd.
  • Massachusetts Eye and Ear Infirmary
  • Next Dimension Ltd.
  • OcuSciences, Inc.
  • Ocutronics, LLC
  • Optos Plc
  • PCAsso Diagnostics LLC
  • Praevium Research Inc.
  • Predictek, Inc.
  • Rensselaer Polytechnic Institute
  • RetiVue, LLC
  • Tufts University
  • University College London
  • University of Arizona
  • University of California, Berkeley
  • University of Valencia
  • Vision Instruments Pty. Ltd.
  • VisionQuest Biomedical, LLC
  • Visual Pathways, Inc. (Inactive)

第6章 眼科向け画像装置市場:昨今の動向

第7章 付録

図表一覧

図表

List of Tables

  • Table 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Table 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment
  • Table 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory
  • Table 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
  • Table 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Table 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials
  • Table 7: Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
  • Table 8: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Table 9: ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Artemis 3 - Product Status
  • Table 11: Artemis 3 - Product Description
  • Table 12: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Diagnostic Tool - Retinal Disorders - Product Status
  • Table 14: Diagnostic Tool - Retinal Disorders - Product Description
  • Table 15: Bioinformative Institute of India Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Ocular Surface Disease Diagnostic System - Product Status
  • Table 17: Ocular Surface Disease Diagnostic System - Product Description
  • Table 18: Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Advanced Retinal Imaging System - Product Status
  • Table 20: Advanced Retinal Imaging System - Product Description
  • Table 21: Broadspot Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Ultrawidefield Imaging Device - Product Status
  • Table 23: Ultrawidefield Imaging Device - Product Description
  • Table 24: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: 3-D Microscopic Ultrasound System - Product Status
  • Table 26: 3-D Microscopic Ultrasound System - Product Description
  • Table 27: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Photoacoustic Imaging System - Product Status
  • Table 29: Photoacoustic Imaging System - Product Description
  • Table 30: CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: RetinalImager - Product Status
  • Table 32: RetinalImager - Product Description
  • Table 33: Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Eye Imaging Device - Product Status
  • Table 35: Eye Imaging Device - Product Description
  • Table 36: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Stereoscopic Heads-Up Display - Product Status
  • Table 38: Stereoscopic Heads-Up Display - Product Description
  • Table 39: Eye Marker Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: RTD 1000 - Product Status
  • Table 41: RTD 1000 - Product Description
  • Table 42: Eyenuk Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: EyeSeeAMD - Product Status
  • Table 44: EyeSeeAMD - Product Description
  • Table 45: Fovioptics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Retinal Blood Analyzer - Product Status
  • Table 47: Retinal Blood Analyzer - Product Description
  • Table 48: Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Motorized C-arm System - Product Status
  • Table 50: Motorized C-arm System - Product Description
  • Table 51: George Washington University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: iEye - Product Status
  • Table 53: iEye - Product Description
  • Table 54: iHealthScreen Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Age Related Macular Degeneration Screening Device - Product Status
  • Table 56: Age Related Macular Degeneration Screening Device - Product Description
  • Table 57: Kaleyedos Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Wireless Retinal Imaging Device - Product Status
  • Table 59: Wireless Retinal Imaging Device - Product Description
  • Table 60: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Portable Mydriatic Cameras - Product Status
  • Table 62: Portable Mydriatic Cameras - Product Description
  • Table 63: Retina Camera - Product Status
  • Table 64: Retina Camera - Product Description
  • Table 65: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Victaz Device - Product Status
  • Table 67: Victaz Device - Product Description
  • Table 68: NeuroVision Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Retinal Imaging System - Product Status
  • Table 70: Retinal Imaging System - Product Description
  • Table 71: NeuroVision Imaging LLC - Ongoing Clinical Trials Overview
  • Table 72: Retinal Imaging System - Anti-amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
  • Table 73: Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Retinal Spectral Imaging System - Product Status
  • Table 75: Retinal Spectral Imaging System - Product Description
  • Table 76: OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: OcuMet Beacon - Product Status

List of Figures

  • Figure 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Figure 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment
  • Figure 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory
  • Figure 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
  • Figure 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Figure 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials
目次
Product Code: GDME0855EPD

GlobalData's Medical Devices sector report, "Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2019" provides an overview of Ophthalmic Imaging Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Imaging Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ophthalmic Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Ophthalmic Imaging Equipment Overview 9

3 Products under Development 10

  • 3.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 10
  • 3.2 Ophthalmic Imaging Equipment - Pipeline Products by Segment 11
  • 3.3 Ophthalmic Imaging Equipment - Pipeline Products by Territory 12
  • 3.4 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 13
  • 3.5 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 14
  • 3.6 Ophthalmic Imaging Equipment - Ongoing Clinical Trials 15

4 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies 16

  • 4.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development 16
  • 4.2 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 18

5 Ophthalmic Imaging Equipment Companies and Product Overview 20

  • 5.1 ArcScan, Inc. Company Overview 20
    • 5.1.1 ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.2 Ben-Gurion University of the Negev Company Overview 21
    • 5.2.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Bioinformative Institute of India Company Overview 22
    • 5.3.1 Bioinformative Institute of India Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Brien Holden Vision Institute Company Overview 23
    • 5.4.1 Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 Broadspot Imaging Corp Company Overview 24
    • 5.5.1 Broadspot Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.6 Case Western Reserve University Company Overview 25
    • 5.6.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.7 Columbia University Company Overview 26
    • 5.7.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.8 CW Optics Inc Company Overview 27
    • 5.8.1 CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.9 Dalhousie University Company Overview 28
    • 5.9.1 Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.10 Duke University Company Overview 29
    • 5.10.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.11 Eye Marker Systems Inc (Inactive) Company Overview 30
    • 5.11.1 Eye Marker Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.12 Eyenuk Inc. Company Overview 31
    • 5.12.1 Eyenuk Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.13 Fovioptics, Inc. (Inactive) Company Overview 32
    • 5.13.1 Fovioptics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.14 Gemss Co.,Ltd. Company Overview 33
    • 5.14.1 Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.15 George Washington University Company Overview 34
    • 5.15.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.16 iHealthScreen Inc Company Overview 35
    • 5.16.1 iHealthScreen Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.17 Kaleyedos Company Overview 36
    • 5.17.1 Kaleyedos Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.18 Massachusetts Eye and Ear Infirmary Company Overview 37
    • 5.18.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.19 National University of Singapore Company Overview 39
    • 5.19.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.20 NeuroVision Imaging LLC Company Overview 40
    • 5.20.1 NeuroVision Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.21 Next Dimension Ltd. Company Overview 43
    • 5.21.1 Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.22 OcuSciences, Inc. Company Overview 44
    • 5.22.1 OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.23 Ocutronics, LLC Company Overview 45
    • 5.23.1 Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.24 Ohio State University Company Overview 46
    • 5.24.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.25 Optos Plc Company Overview 47
    • 5.25.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.26 Physical Sciences Inc Company Overview 52
    • 5.26.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.27 Praevium Research Inc. Company Overview 53
    • 5.27.1 Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.28 Predictek Inc Company Overview 54
    • 5.28.1 Predictek Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.29 Rensselaer Polytechnic Institute Company Overview 55
    • 5.29.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.30 RetiVue, LLC Company Overview 56
    • 5.30.1 RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.31 Ti-TaMed (PTY) LTD. Company Overview 59
    • 5.31.1 Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.32 Tufts University Company Overview 60
    • 5.32.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.33 University College London Company Overview 61
    • 5.33.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.34 University of Arizona Company Overview 62
    • 5.34.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.35 University of California Los Angeles Company Overview 63
    • 5.35.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.36 University of Colorado Company Overview 64
    • 5.36.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.37 University of South Florida Company Overview 65
    • 5.37.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.38 University of Valencia Company Overview 66
    • 5.38.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.39 Vasoptic Medical, Inc. Company Overview 67
    • 5.39.1 Vasoptic Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.40 Vision Instruments Pty. Ltd. Company Overview 70
    • 5.40.1 Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.41 VisionQuest Biomedical LLC Company Overview 71
    • 5.41.1 VisionQuest Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.42 Visual Pathways, Inc. (Inactive) Company Overview 74
    • 5.42.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74

6 Ophthalmic Imaging Equipment- Recent Developments 76

  • 6.1 Nov 15, 2019: Vision Source Senior Vice President appointed to the University of Houston System Board of Regents by Texas Governor 76
  • 6.2 Nov 12, 2019: ArcScan announces launch of Iclsizing website by London Vision Clinic, Dan Reinstein, MD 76
  • 6.3 Nov 07, 2019: Phoenix Technology Group adds enterprise-class security and Windows 10 support to the Phoenix ICON wide-field retinal imaging system 77
  • 6.4 Oct 31, 2019: Encouraging additional phase 3 data presented for Abicipar, and start of phase 1 trial for MP0310, the first immuno-oncology DARPin(R) with a novel therapeutic design 78
  • 6.5 Oct 31, 2019: Interim management statement - Q3 2019: Encouraging additional phase 3 data presented for Abicipar, and start of phase 1 trial for MP0310, the first immuno-oncology Darpin with a novel therapeutic design 80

7 Appendix 124

  • 7.1 Methodology 124
  • 7.2 About GlobalData 127
  • 7.3 Contact Us 127
  • 7.4 Disclaimer 127